Yonhap KoreanKO
대웅제약, 염증성 장질환 치료제 국내 임상 1상 진입
(서울=연합뉴스) 박상현 기자 = 대웅제약[069620]은 염증성 장질환 치료제 후보물질 'DWP309008'의 국내 임상 1상 시험계획(IND...
🇰🇷 대한민국 / 한국어
The world, in perspective.
Fresh headlines from around the world. Gaming, politics, technology and everything in between.
Allnira republishes accessible articles under owner-declared permissions, with original authors, publishers and image credits. Automatic cloud imports run hourly; open pages check for updates every 15 seconds. Publication delays depend on each feed.